Vipadenant (INN, USAN; developmental code name BIIB014 and others) is an adenosine A2A receptor antagonist which was under development for the treatment of Parkinson's disease and cancer but was never marketed.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.